Journal of immunotherapy (Hagerstown, Md. : 1997)
FGL1 as an Immune Checkpoint in the Immune Microenvironment of Bladder Cancer.
Keyao Hu, Xiaocheng Ma, Lei Luo, Peng Li
Published: 202510.1097/CJI.0000000000000595
Abstract
Current treatment protocols for bladder cancer (BC) do not include additional immune checkpoint targets or biomarkers that can accurately predict treatment response. Hence, it is imperative to identify more inclusive and promising candidate compounds…
Preview only. Read the full abstract at the source